April 22, 2026 · Form 4 insider transaction
Tamboli Ajim bought 41,233 shares of First Tracks Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
The stock option vests as to 25% of the total shares on April 20, 2027, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.